CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Adrian Dunlop - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Adrian Dunlop

OPENALEX: A5008990660↗ORCID: 0000-0003-2394-5966↗

Affiliations

Organizations

Hunter Medical Research Instituteauthorship · AU Hunter New England Local Health Districtauthorship · AU Northern Sydney Local Health Districtauthorship · AU University of Newcastle Australiaauthorship · AU UNSW Sydneyauthorship · AU

Public evidence

5 connected articles

Clinicians' attitudes and knowledge of medicinal cannabis in opioid dependence treatment clinics in New South Wales, Australia.2025 · Europe PMC A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.2024 · Europe PMC Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder.2022 · Europe PMC The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients.2021 · Europe PMC Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.2018 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.